Cargando…

The Interplay between Dysregulated Metabolism and Epigenetics in Cancer

Cellular metabolism (or energetics) and epigenetics are tightly coupled cellular processes. It is arguable that of all the described cancer hallmarks, dysregulated cellular energetics and epigenetics are the most tightly coregulated. Cellular metabolic states regulate and drive epigenetic changes wh...

Descripción completa

Detalles Bibliográficos
Autor principal: Bassal, Mahmoud Adel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296273/
https://www.ncbi.nlm.nih.gov/pubmed/37371524
http://dx.doi.org/10.3390/biom13060944
_version_ 1785063619071836160
author Bassal, Mahmoud Adel
author_facet Bassal, Mahmoud Adel
author_sort Bassal, Mahmoud Adel
collection PubMed
description Cellular metabolism (or energetics) and epigenetics are tightly coupled cellular processes. It is arguable that of all the described cancer hallmarks, dysregulated cellular energetics and epigenetics are the most tightly coregulated. Cellular metabolic states regulate and drive epigenetic changes while also being capable of influencing, if not driving, epigenetic reprogramming. Conversely, epigenetic changes can drive altered and compensatory metabolic states. Cancer cells meticulously modify and control each of these two linked cellular processes in order to maintain their tumorigenic potential and capacity. This review aims to explore the interplay between these two processes and discuss how each affects the other, driving and enhancing tumorigenic states in certain contexts.
format Online
Article
Text
id pubmed-10296273
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102962732023-06-28 The Interplay between Dysregulated Metabolism and Epigenetics in Cancer Bassal, Mahmoud Adel Biomolecules Review Cellular metabolism (or energetics) and epigenetics are tightly coupled cellular processes. It is arguable that of all the described cancer hallmarks, dysregulated cellular energetics and epigenetics are the most tightly coregulated. Cellular metabolic states regulate and drive epigenetic changes while also being capable of influencing, if not driving, epigenetic reprogramming. Conversely, epigenetic changes can drive altered and compensatory metabolic states. Cancer cells meticulously modify and control each of these two linked cellular processes in order to maintain their tumorigenic potential and capacity. This review aims to explore the interplay between these two processes and discuss how each affects the other, driving and enhancing tumorigenic states in certain contexts. MDPI 2023-06-05 /pmc/articles/PMC10296273/ /pubmed/37371524 http://dx.doi.org/10.3390/biom13060944 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bassal, Mahmoud Adel
The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
title The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
title_full The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
title_fullStr The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
title_full_unstemmed The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
title_short The Interplay between Dysregulated Metabolism and Epigenetics in Cancer
title_sort interplay between dysregulated metabolism and epigenetics in cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10296273/
https://www.ncbi.nlm.nih.gov/pubmed/37371524
http://dx.doi.org/10.3390/biom13060944
work_keys_str_mv AT bassalmahmoudadel theinterplaybetweendysregulatedmetabolismandepigeneticsincancer
AT bassalmahmoudadel interplaybetweendysregulatedmetabolismandepigeneticsincancer